These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28043910)

  • 1. Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.
    Tong D; Liu Q; Liu G; Xu J; Lan W; Jiang Y; Xiao H; Zhang D; Jiang J
    Cancer Lett; 2017 Mar; 389():23-32. PubMed ID: 28043910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.
    Liu Q; Yuan W; Tong D; Liu G; Lan W; Zhang D; Xiao H; Zhang Y; Huang Z; Yang J; Zhang J; Jiang J
    Oncotarget; 2016 May; 7(19):28235-46. PubMed ID: 27058422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
    Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
    Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
    Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT.
    Liu Q; Tong D; Liu G; Xu J; Do K; Geary K; Zhang D; Zhang J; Zhang Y; Li Y; Bi G; Lan W; Jiang J
    Cell Death Dis; 2017 Aug; 8(8):e3007. PubMed ID: 28837141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.
    Zhao Z; Cheng X; Wang Y; Han R; Li L; Xiang T; He L; Long H; Zhu B; He Y
    PLoS One; 2014; 9(4):e95884. PubMed ID: 24789104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
    Cheng K; Hao M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
    Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
    Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.
    Leonel C; Borin TF; de Carvalho Ferreira L; Moschetta MG; Bajgelman MC; Viloria-Petit AM; de Campos Zuccari DA
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):27-41. PubMed ID: 28078601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
    Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration.
    Liu Q; Tong D; Liu G; Gao J; Wang LA; Xu J; Yang X; Xie Q; Huang Y; Pang J; Wang L; He Y; Zhang D; Ma Q; Lan W; Jiang J
    Clin Cancer Res; 2018 Nov; 24(22):5622-5634. PubMed ID: 30012567
    [No Abstract]   [Full Text] [Related]  

  • 15. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
    Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
    Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.
    Shiota M; Bishop JL; Nip KM; Zardan A; Takeuchi A; Cordonnier T; Beraldi E; Bazov J; Fazli L; Chi K; Gleave M; Zoubeidi A
    Cancer Res; 2013 May; 73(10):3109-19. PubMed ID: 23492367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.